John Wood sees Government Defence and Green Energy Reviews as positive for InfraStrata #INFA Watch Now

Less Ads, More Data, More Tools Register for FREE
John Wood sees Government Defence and Green Energy Reviews as positive for InfraStrata #INFA
John Wood sees Government Defence and Green Energy Reviews as positive for InfraStrata #INFAView Video
Hardman & Co Mining Forum: Scotgold #SGZ prepare for production at Scottish gold/silver mine
Hardman & Co Mining Forum: Scotgold #SGZ prepare for production at Scottish gold/silver mineView Video

Pin to quick picksSensyne Health. Share News (SENS)

Share Price Information for Sensyne Health. (SENS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 139.00
Bid: 136.00
Ask: 142.00
Change: -11.00 (-7.33%)
Spread: 6.00 (4.41%)
Open: 152.00
High: 142.00
Low: 139.00
Yest. Close: 150.00
SENS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Sensyne Health Partners With Microsoft To Develop AI Technology

Wed, 28th Oct 2020 15:33

(Alliance News) - Sensyne Health PLC on Wednesday said it has formed a strategic partnership with US-based software giant Microsoft Inc to further develop and refine Sensyne's clinical artificial intelligent and health cloud technologies to improve, augment, and reduce the cost of patient care.

Under the agreement, medical technology company Sensyne will combine its expertise in remote monitoring, clinically led digital technologies and machine learning algorithms with Microsoft's healthcare capabilities such as Health Cloud, Virtual Consult, Healthcare Accelerator, Health Bot, and Azure internet of things for clinical use.

The partnership will increase Sensyne's ability to create scalable and configurable healthcare technologies that are globally deployable and able to meet local, clinical and regulatory needs, the UK-based company explained. Sensyne will have early access to Microsoft tools enabling it to build new products with features to enhance usability and cyber-security.

Shares in Sensyne Health were up 8.5% at 115.0 pence each in London on Wednesday afternoon.

By Tapan Panchal; tapanpanchal@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News

IN BRIEF: Sensyne Health Achieves Five Million Patient Target

IN BRIEF: Sensyne Health Achieves Five Million Patient Target

16 Nov 20 11:41

UK EXECUTIVE CHANGE SUMMARY: Shake-Up Of Primorus Board Continues

UK EXECUTIVE CHANGE SUMMARY: Shake-Up Of Primorus Board Continues

13 Nov 20 14:43

Sensyne taps Derek Baird to lead North American expansion

(Sharecast News) - Clinical AI company Sensyne has tapped Derek Baird to take on the role of North American president as the group looks to advance its expansion into the region.

13 Nov 20 09:25

UK TRADING UPDATE SUMMARY: Sensyne App Used In Oxford Covid Study

UK TRADING UPDATE SUMMARY: Sensyne App Used In Oxford Covid Study

2 Nov 20 20:03

Sensyne Health app to be used in Covid-19 study

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health announced on Monday that its 'CVm-Health+' app is to be used by the University of Oxford in its 'FACTS' clinical study evaluating the feasibility and acceptability of new point-of-care tests for regular asymptomatic Covid-19 testing in the community.

2 Nov 20 09:27

Sensyne Health Partners With Microsoft To Develop AI Technology

Sensyne Health Partners With Microsoft To Develop AI Technology

28 Oct 20 15:33

IN BRIEF: Sensyne Partners With Milton Keynes University Hospital

IN BRIEF: Sensyne Partners With Milton Keynes University Hospital

26 Oct 20 17:43

IN BRIEF: Sensyne Health Partners Up With Bristol Myers Squibb

IN BRIEF: Sensyne Health Partners Up With Bristol Myers Squibb

23 Oct 20 16:37

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

23 Oct 20 16:04

Sensyne Health signs research collaboration deal with Bristol Myers Squibb

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed a research collaboration agreement with Bristol Myers Squibb, it announced on Friday.

23 Oct 20 11:44

IN BRIEF: Sensyne Signs Data Sharing Deal With NHS Greater Glasgow

IN BRIEF: Sensyne Signs Data Sharing Deal With NHS Greater Glasgow

1 Oct 20 17:49

IN BRIEF: Sensyne Health To Provide Software For Covid Treatment Trial

IN BRIEF: Sensyne Health To Provide Software For Covid Treatment Trial

30 Sep 20 21:37

UK EARNINGS SUMMARY: Gama Aviation Interim Loss Widens As Revenue Down

UK EARNINGS SUMMARY: Gama Aviation Interim Loss Widens As Revenue Down

30 Sep 20 21:13

Acacia Research buys 11.8% stake in Sensyne Health

(Sharecast News) - US-based Acacia Research has acquired LF Equity Income Fund's 11.8% stake in AIM-listed artificial intelligence specialist Sensyne Health.

29 Sep 20 12:45

IN BRIEF: Sensyne Health Names Macdonnell As New Operating Chief

IN BRIEF: Sensyne Health Names Macdonnell As New Operating Chief

10 Sep 20 19:21

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.